Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide.

Yamamoto K, Kitawaki T, Sugimoto N, Fujita H, Kawase Y, Takaori-Kondo A, Kadowaki N.

Immunol Lett. 2019 Jul;211:41-48. doi: 10.1016/j.imlet.2019.05.012. Epub 2019 May 26.

PMID:
31141702
2.

Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces.

Kadota K, Kushida Y, Kagawa S, Ishikawa R, Ibuki E, Inoue K, Go T, Yokomise H, Ishii T, Kadowaki N, Haba R.

Am J Surg Pathol. 2019 Aug;43(8):1033-1041. doi: 10.1097/PAS.0000000000001285.

PMID:
31107717
3.

Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.

Wakiya R, Kameda T, Ueeda K, Nakashima S, Shimada H, Mansour MF, Kato M, Miyagi T, Miyatake N, Kadowaki N, Dobashi H.

Lupus. 2019 Jun;28(7):826-833. doi: 10.1177/0961203319846391. Epub 2019 May 8.

PMID:
31068068
4.

Graft failure after reduced-intensity stem cell transplantation for congenital sideroblastic anemia.

Imataki O, Uchida S, Uemura M, Kadowaki N.

Pediatr Hematol Oncol. 2019 Feb;36(1):46-51. doi: 10.1080/08880018.2019.1578844. Epub 2019 Mar 26.

PMID:
30912988
5.

Lethal cardiac damage resulting from eosinophilia caused by anaplastic large cell lymphoma.

Imataki O, Uemura M, Kadowaki N.

Br J Haematol. 2019 May;185(4):642. doi: 10.1111/bjh.15809. Epub 2019 Feb 21. No abstract available.

PMID:
30793295
6.

Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers.

Shimada H, Kameda T, Kanenishi K, Miyatake N, Nakashima S, Wakiya R, Kato M, Miyagi T, Mansour MMF, Hata T, Kadowaki N, Dobashi H.

Clin Rheumatol. 2019 May;38(5):1453-1458. doi: 10.1007/s10067-019-04450-3. Epub 2019 Feb 7.

PMID:
30729372
7.

Central Nervous System Peripheral T Cell Lymphoma Manifesting as Lymphomatosis Cerebri That Was Misdiagnosed as Neuro-Behçet's Disease: A Case Report.

Imataki O, Uchida S, Yokokura S, Uemura M, Kadowaki N.

Case Rep Oncol. 2018 Nov 29;11(3):806-813. doi: 10.1159/000495033. eCollection 2018 Sep-Dec.

8.

c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia.

Kubo H, Imataki O, Kubo YH, Uemura M, Kadowaki N.

Int J Clin Oncol. 2019 May;24(5):590-595. doi: 10.1007/s10147-018-01384-9. Epub 2019 Jan 2.

PMID:
30604157
9.

Small Primary Cutaneous γδT-Cell Lymphoma Lesions Successfully Treated With Pralatrexate.

Imataki O, Uchida S, Yokokura S, Uemura M, Kadowaki N.

Clin Nucl Med. 2019 Feb;44(2):e85-e86. doi: 10.1097/RLU.0000000000002409.

PMID:
30516664
10.

The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions.

Watanabe N, Ishii T, Kita N, Kanaji N, Nakamura H, Nanki N, Ueda Y, Tojo Y, Kadowaki N, Bandoh S.

BMC Pulm Med. 2018 Nov 23;18(1):176. doi: 10.1186/s12890-018-0740-3.

11.

Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma.

Kadota K, Kushida Y, Kagawa S, Ishikawa R, Ibuki E, Inoue K, Go T, Yokomise H, Ishii T, Kadowaki N, Haba R.

J Thorac Oncol. 2019 Feb;14(2):245-254. doi: 10.1016/j.jtho.2018.09.028. Epub 2018 Oct 15.

PMID:
30336325
12.

[Cancer therapy using bispecific antibodies].

Kadowaki N.

Rinsho Ketsueki. 2018;59(10):1942-1947. doi: 10.11406/rinketsu.59.1942. Review. Japanese.

PMID:
30305495
13.

Pulmonary Multiloculated 'Lotus Torus-like' Sarcoidosis Mimicking Lung Adenocarcinoma.

Kanaji N, Nakashima N, Inoue T, Ibuki E, Murota M, Kadowaki N.

Intern Med. 2019 Feb 1;58(3):419-422. doi: 10.2169/internalmedicine.1541-18. Epub 2018 Sep 12.

14.

Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation.

Kanaji N, Mizoguchi H, Inoue T, Tadokoro A, Watanabe N, Ishii T, Tojo Y, Yamaguchi M, Kadowaki N.

Ther Clin Risk Manag. 2018 Aug 1;14:1361-1368. doi: 10.2147/TCRM.S164700. eCollection 2018.

15.

Subacute Sensorimotor Neuropathy Accompanied by Anti-ganglioside GM1 Antibody in a Patient with Lung Cancer.

Kanaji N, Kume K, Mizoguchi H, Inoue T, Watanabe N, Nishiyama N, Kadowaki N, Ishii T.

Intern Med. 2018 Nov 15;57(22):3289-3292. doi: 10.2169/internalmedicine.0667-17. Epub 2018 Jul 6.

16.

Pure erythroid leukemia in a polymyositis patient treated with azathioprine.

Imataki O, Takeuchi A, Uchida S, Yokokura S, Uemura M, Kadowaki N.

Rare Tumors. 2018 May 14;10:2036361318773847. doi: 10.1177/2036361318773847. eCollection 2018.

17.

Transforming Growth Factor-Beta Produced by Non-small Cell Lung Cancer Cells Contributes to Lung Fibroblast Contractile Phenotype.

Kanaji N, Yokohira M, Watanabe N, Kadowaki N, Bandoh S.

Anticancer Res. 2018 Apr;38(4):2007-2014.

PMID:
29599317
18.

Unusually Long-Wavelength Emissions of Cyclopropanes: New Insight into C-C Bond Homolysis.

Abe M, Kanahara K, Kadowaki N, Tan CJ, Tsai HG.

Chemistry. 2018 May 28;24(30):7595-7600. doi: 10.1002/chem.201800671. Epub 2018 Apr 23.

PMID:
29573002
19.

Lemongrass essential oil and citral inhibit Src/Stat3 activity and suppress the proliferation/survival of small-cell lung cancer cells, alone or in combination with chemotherapeutic agents.

Maruoka T, Kitanaka A, Kubota Y, Yamaoka G, Kameda T, Imataki O, Dobashi H, Bandoh S, Kadowaki N, Tanaka T.

Int J Oncol. 2018 Mar 13. doi: 10.3892/ijo.2018.4314. [Epub ahead of print]

PMID:
29568932
20.

Bendamustine and G-CSF support.

Imataki O, Uchida S, Yokokura S, Uemura M, Kadowaki N.

Support Care Cancer. 2019 May;27(5):1581-1582. doi: 10.1007/s00520-018-4118-0. Epub 2018 Feb 26. No abstract available.

PMID:
29484498
21.

Guest editorial: advances in immunotherapy for hematological malignancies.

Kadowaki N.

Int J Hematol. 2018 Mar;107(3):260-261. doi: 10.1007/s12185-018-2420-8. Epub 2018 Feb 9. No abstract available.

PMID:
29427173
22.

Additive antitumour effect of D‑allose in combination with cisplatin in non-small cell lung cancer cells.

Kanaji N, Kamitori K, Hossain A, Noguchi C, Katagi A, Kadowaki N, Tokuda M.

Oncol Rep. 2018 Mar;39(3):1292-1298. doi: 10.3892/or.2018.6192. Epub 2018 Jan 4.

PMID:
29328484
23.

Magnetically Bistable Nitrenes: Matrix Isolation of Furoylnitrenes in Both Singlet and Triplet States and Triplet 3-Furylnitrene.

Feng R, Lu Y, Deng G, Xu J, Wu Z, Li H, Liu Q, Kadowaki N, Abe M, Zeng X.

J Am Chem Soc. 2018 Jan 10;140(1):10-13. doi: 10.1021/jacs.7b08957. Epub 2017 Dec 19.

PMID:
29241334
24.

Cytomegalovirus pulls strings behind NK cells.

Kadowaki N, Ishiyama K, Kitawaki T.

Oncotarget. 2017 Sep 28;8(55):93297-93298. doi: 10.18632/oncotarget.21377. eCollection 2017 Nov 7. No abstract available.

25.

Complete mimicry: a case of alveolar rhabdomyosarcoma masquerading as acute leukemia.

Imataki O, Uemura M, Uchida S, Yokokura S, Takeuchi A, Ishikawa R, Kondo A, Seo K, Kadowaki N.

Diagn Pathol. 2017 Nov 2;12(1):77. doi: 10.1186/s13000-017-0667-7.

26.

Amelioration of NK cell function driven by Vα24+ invariant NKT cell activation in multiple myeloma.

Iyoda T, Yamasaki S, Hidaka M, Kawano F, Abe Y, Suzuki K, Kadowaki N, Shimizu K, Fujii SI.

Clin Immunol. 2018 Feb;187:76-84. doi: 10.1016/j.clim.2017.10.007. Epub 2017 Oct 20.

PMID:
29061445
27.

Anemia and hypogammaglobulinemia caused by Ménétrier's disease.

Imataki O, Uchida S, Yokokura S, Uemura M, Kadowaki N.

Int J Hematol. 2018 Jan;107(1):3-4. doi: 10.1007/s12185-017-2349-3. Epub 2017 Oct 12. No abstract available.

PMID:
29027113
28.

Methionine PET Might Be Reliable for the Detection of Low M-Protein-Producing Myelomas.

Imataki O, Uchida S, Yokokura S, Uemura M, Kadowaki N.

Clin Nucl Med. 2017 Nov;42(11):e469-e471. doi: 10.1097/RLU.0000000000001821.

PMID:
28872550
29.

Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.

Kanaji N, Sakai K, Ueda Y, Miyawaki H, Ishii T, Watanabe N, Kita N, Kadota K, Kadowaki N, Bandoh S.

Lung Cancer. 2017 Jun;108:126-133. doi: 10.1016/j.lungcan.2017.03.013. Epub 2017 Mar 27.

PMID:
28625624
30.

Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression.

Kanaji N, Yokohira M, Nakano-Narusawa Y, Watanabe N, Imaida K, Kadowaki N, Bandoh S.

Respir Res. 2017 Jun 15;18(1):118. doi: 10.1186/s12931-017-0604-z.

31.
32.

Phanerochaete sordida as a cause of pulmonary nodule in an immunocompromised patient: a case report.

Watanabe N, Ohkusu K, Okuda M, Imataki O, Ishii T, Negayama K, Tadokoro A, Kita N, Takagi T, Kanaji N, Kadowaki N, Bandoh S.

BMC Infect Dis. 2017 Feb 10;17(1):135. doi: 10.1186/s12879-017-2244-9.

33.

Infective endocarditis and infected aneurysm caused by Streptococcus dysgalactiae subsp. equisimilis: a case report.

Watanabe N, Bandoh S, Ishii T, Negayama K, Kadowaki N, Yokota K.

Clin Case Rep. 2017 Jan 24;5(2):187-192. doi: 10.1002/ccr3.829. eCollection 2017 Feb.

34.

Case of EGPA and Eosinophilic Chronic Rhinosinusitis Concomitant with IgG4 Related Disease.

Akiyama K, Yonezaki M, Dobashi H, Kameda T, Hoshikawa H, Kadowaki N.

Nihon Jibiinkoka Gakkai Kaiho. 2017 Feb;120(2):123-30. Review. Japanese.

PMID:
30033930
35.

Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study.

Uemura M, Imataki O, Uchida S, Nakayama-Imaohji H, Ohue Y, Matsuka H, Mori H, Dobashi H, Kuwahara T, Kadowaki N.

BMC Infect Dis. 2017 Jan 5;17(1):26. doi: 10.1186/s12879-016-2144-4.

36.

Enteral Malakoplakia Prior to Helicobacter cinaedi Bacteremia.

Imataki O, Kawashima K, Uchida S, Yokokura S, Uemura M, Kadowaki N.

Am J Gastroenterol. 2017 Jan;112(1):187-188. doi: 10.1038/ajg.2016.514. No abstract available.

PMID:
28050043
37.

Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib.

Ishiyama K, Kitawaki T, Sugimoto N, Sozu T, Anzai N, Okada M, Nohgawa M, Hatanaka K, Arima N, Ishikawa T, Tabata S, Onaka T, Oka S, Nakabo Y, Amakawa R, Matsui M, Moriguchi T, Takaori-Kondo A, Kadowaki N.

Leukemia. 2017 Jan;31(1):268. doi: 10.1038/leu.2016.188. No abstract available.

PMID:
28050024
38.

An autopsy case of bronchiolitis obliterans as a previously unrecognized adverse event of afatinib treatment.

Kanaji N, Chiba Y, Sato A, Ueno M, Tadokoro A, Kita N, Ishii T, Watanabe N, Kadowaki N, Bandoh S.

Respir Investig. 2017 Jan;55(1):58-62. doi: 10.1016/j.resinv.2016.09.002. Epub 2016 Oct 27.

PMID:
28012496
39.

Regeneration of CD8αβ T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity.

Maeda T, Nagano S, Ichise H, Kataoka K, Yamada D, Ogawa S, Koseki H, Kitawaki T, Kadowaki N, Takaori-Kondo A, Masuda K, Kawamoto H.

Cancer Res. 2016 Dec 1;76(23):6839-6850. Epub 2016 Nov 21.

40.

Bone Marrow and Peripheral Blood: Which Is Safe?

Imataki O, Uchida S, Yokokura S, Uemura M, Matsushita K, Kadowaki N.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2283-2284. doi: 10.1016/j.bbmt.2016.09.015. Epub 2016 Sep 19. No abstract available.

41.

Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor.

Uemura M, Imataki O, Kawachi Y, Kawakami K, Hoshijima Y, Matsuoka A, Kadowaki N.

Int J Hematol. 2016 Nov;104(5):621-627. Epub 2016 Aug 4.

PMID:
27492732
42.

Paradoxical thrombosis in idiopathic thrombocytopenic purpura.

Imataki O, Uchida S, Yokokura S, Uemura M, Kadowaki N.

Int J Hematol. 2017 Feb;105(2):111-112. doi: 10.1007/s12185-016-2117-9. Epub 2016 Oct 22. No abstract available.

PMID:
27771836
43.

Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival.

Kanaji N, Tadokoro A, Kita N, Murota M, Ishii T, Takagi T, Watanabe N, Tojo Y, Harada S, Hasui Y, Kadowaki N, Bandoh S.

J Cancer Res Clin Oncol. 2016 Aug;142(8):1855-65. doi: 10.1007/s00432-016-2199-z. Epub 2016 Jun 27.

44.

Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib.

Ishiyama K, Kitawaki T, Sugimoto N, Sozu T, Anzai N, Okada M, Nohgawa M, Hatanaka K, Arima N, Ishikawa T, Tabata S, Onaka T, Oka S, Nakabo Y, Amakawa R, Matsui M, Moriguchi T, Takaori-Kondo A, Kadowaki N.

Leukemia. 2017 Jan;31(1):203-212. doi: 10.1038/leu.2016.174. Epub 2016 Jun 14. Erratum in: Leukemia. 2017 Jan;31(1):268. Ishiyama, K-I [corrected to Ishiyama, K].

PMID:
27349810
45.

An Uncharted Constellation: TAFRO Syndrome.

Tadokoro A, Kanaji N, Hara T, Matsumoto K, Ishii T, Takagi T, Watanabe N, Kita N, Kawauchi M, Ueno M, Kadowaki N, Bandoh S.

Am J Med. 2016 Sep;129(9):938-41. doi: 10.1016/j.amjmed.2016.05.010. Epub 2016 Jun 4. No abstract available.

PMID:
27267287
46.

Antilymphocyte Globulin for Chronic Graft-versus-Host Disease.

Imataki O, Uemura M, Kadowaki N.

N Engl J Med. 2016 May 12;374(19):1894. doi: 10.1056/NEJMc1601364. No abstract available.

PMID:
27168442
47.

Confluence-dependent resistance to cisplatin in lung cancer cells is regulated by transforming growth factor-beta.

Yokokura S, Kanaji N, Tadokoro A, Yokokura S, Kadowaki N, Bandoh S.

Exp Lung Res. 2016 May;42(4):175-81. doi: 10.3109/01902148.2016.1172370. Epub 2016 Apr 26.

PMID:
27116015
48.

Vimentin Regulates Invasiveness and Is a Poor Prognostic Marker in Non-small Cell Lung Cancer.

Tadokoro A, Kanaji N, Liu D, Yokomise H, Haba R, Ishii T, Takagi T, Watanabe N, Kita N, Kadowaki N, Bandoh S.

Anticancer Res. 2016 Apr;36(4):1545-51.

PMID:
27069130
49.

A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine.

Umeda M, Kondo T, Nishikori M, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A.

Clin Case Rep. 2015 Nov 9;4(1):23-5. doi: 10.1002/ccr3.436. eCollection 2016 Jan.

50.

Supplemental Content

Loading ...
Support Center